KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Mechanistic Biomarkers in Acute Liver Injury

    Thumbnail
    View/Open
    Weemhoff_ku_0099D_15636_DATA_1.pdf (1.436Mb)
    Issue Date
    2017-12-31
    Author
    Weemhoff, James Lawrence
    Publisher
    University of Kansas
    Format
    135 pages
    Type
    Dissertation
    Degree Level
    Ph.D.
    Discipline
    Pharmacology, Toxicology & Therapeutics
    Rights
    Copyright held by the author.
    Metadata
    Show full item record
    Abstract
    Acute liver failure continues to be a major medical problem. There are many underlying causes of acute liver failure, but drug induced liver injury is the most common. However, ischemic injury secondary to either liver transplantation or hypoxic hepatitis are also commonly encountered clinically. While the pathogenesis of some etiologies of liver failure are well known due to appropriate animal and cell culture models (i.e. acetaminophen toxicity), that of ischemic injury is not as well documented. A major reason for this is the lack of appropriate animal models available to recapitulate these conditions in humans. Furthermore, obtaining multiple liver biopsies to study these conditions at the cellular level is generally not possible owing, in part, to the invasive nature of obtaining the sample, but also to the fact that liver biopsies are contraindicated in acute liver injury patients. Thus, alternative methods which can help diagnose and study liver injury are being explored and refined. Among these methods are the use of circulating biomarkers, which are currently being extensively explored in the field of hepatology. Because biologic specimens in which these biomarkers are being measured can be easily obtained and are non-invasive, they offer a promising means by which to study liver injury, particularly for prolonged periods of time. Indeed, a series of blood collections can provide vital information into various injury-specific aspects of liver pathophysiology including mode of cell death, mitochondrial involvement, degree of liver injury, and presence or absence of a sterile inflammatory component to the injurious process. Here, we use a well-established set of circulating plasma biomarkers to study the pathophysiology of both warm and cold ischemia to better characterize the cellular events which take place during these conditions. Data obtained demonstrates that during both warm and cold ischemia, the majority of injury occurs early in the reperfusion period and that necrosis, rather than apoptosis predominates. Furthermore, we identified the mitochondria as critical mediators of liver injury following ischemia. However, we were unable to find evidence of an inflammatory component of ischemic injury. Furthermore, we conclude that due to advances in surgical technique and organ preservation strategies, future efforts to study injury secondary to liver transplantation should focus on the biliary system and the formation of biliary strictures rather than ischemic injury. HepaRG cells are a human hepatoma cell line which is commonly used in the laboratory. Unlike other liver cell lines, HepaRG cells have a full complement of drug metabolizing enzymes, making them ideal for the study of drug induced liver injury. However, growth, maintenance, and differentiation of conventional HepaRG cells is a timely process. Recently, this lengthy process has been dramatically shortened with the advent of pre-differentiated cryopreserved HepaRG cells. Due to the frequency of acetaminophen toxicity, combined with the fact that liver injury is the most common cause of drug failure and market withdrawal, we set out to compare these two preparations of HepaRG cells. Using acetaminophen as a test substrate, we found both preparations of HepaRG to be similar in all aspects of acetaminophen metabolism. This finding will help advance the study of acetaminophen, as well as help identify idiosyncratic adverse drug reactions earlier in the drug development process.
    URI
    http://hdl.handle.net/1808/27044
    Collections
    • Pharmacy Dissertations and Theses [118]
    • Dissertations [4321]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps